Paola Perego - Concepedia

Author

Paola Perego

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

On behalf of the EORTC PAMM Group, P PEREGO, P Perego, P. Perego, Paola Perego, Perego, P

260

Publications

11.4K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Fondazione IRCCS Istituto Neurologico Carlo Besta University of Verona University of Brescia

About

Paola Perego is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	76	5K
2	Natural Sciences	9	9	340
3	Health Sciences	8	8	1.3K
4	Biochemistry	5	5	213
5	Engineering	3	3	111

Paola Perego

117

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Highly tumorigenic lung cancer CD133 <sup>+</sup> cells display stem-like features and are spared by cisplatin treatment Giulia Bertolini, Luca Roz, Paola Perego, Proceedings of the National Academy of Sciences Normal Lung TissuePathologyCancer BiologyTumor BiologyCisplatin Treatment	2009	775
Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles Giovanna Andreola, Licia Rivoltini, Chiara Castelli, The Journal of Experimental Medicine	2002	745
Inhibition of proteasome deubiquitinating activity as a new cancer therapy Pádraig D’Arcy, Slavica Brnjic, Maria Hägg Olofsson, Nature Medicine Proteasome Deubiquitinating ActivityOncologyMedicinePharmacologyProteasome	2011	493
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Paola Perego, Monica Giarola, Sabina Carla Righetti, PubMed P53 StatusReduced Bax ExpressionPathologyCancer BiologyTumor Biology	1996	392
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer Nadia Zaffaroni, Marzia Pennati, Gennaro Colella, Cellular and Molecular Life Sciences Oncogenic AgentMedicineHuman Ovarian CancerPathologyGynecology	2002	274
p53 Gene Status and Response to Platinum/Paclitaxel-Based Chemotherapy in Advanced Ovarian Carcinoma Cinzia Lavarino, Silvana Pilotti, Maria Oggionni, Journal of Clinical Oncology	2000	149
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431 Annalisa Castagna, Paolo Antonioli, Hubert Astner, PROTEOMICS Proteomic ApproachCancer BiologyTumor BiologyDrug ResistanceAnti-cancer Agent	2004	140
A Novel Trinuclear Platinum Complex Overcomes Cisplatin Resistance in an Osteosarcoma Cell System Paola Perego, Claudia Caserini, Laura Gatti, Molecular Pharmacology	1999	122
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts Graziella Pratesi, Paola Perego, Donatella Polizzi, British Journal of Cancer	1999	116
In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems Simona Romanelli, Paola Perego, Graziella Pratesi, Cancer Chemotherapy and Pharmacology OncologyVivo InteractionOvarian Carcinoma SystemsMedicineGynecology	1998	115

Page 1